IMV Inc banner

Intrinsic Value

Not Available for IMVIF

There is not enough data to reliably calculate the intrinsic value for IMV Inc.

Do our valuations actually work? See backtest results .

Alternatives to IMVIF

Fundamental Analysis

What IMV Does

Biotechnology Health Care

IMV, Inc. is a clinical-stage biopharmaceutical company that engages in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company is headquartered in Dartmouth, Nova Scotia and currently employs 97 full-time employees. The company went IPO on 2007-10-24. The firm is using its DPX delivery technology to achieve targeted immune activation.

Headquarters
Canada CA
Employees
97
IPO date
Oct 24, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
IMV Inc

Wall St Price Targets

Capital Returns

Competitive Landscape